Reporter brief
Characterization of mTOR Inhibitor Pharmacokinetics and Pharmacodynamics in Older Adults .
What happened
Trial registry update: RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- This study does not demonstrate whether rapamycin actually slows aging or prevents chronic disease in older adults—it only characterizes how the drug behaves in this population. No clinical efficacy endpoints or health outcomes were reported. The abstract does not describe what was actually found, only what the study was designed to do, so no substantive results can be extracted.
Study design and sample
Rct; Human.
Not recorded.
- Design
- Rct
- Sample
- —
- Journal
- University of Texas Southwestern Medical Center
- Published
- Jun 25, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Rapamycin timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.